New blood test could slash unnecessary colonoscopies for colorectal cancer screening

NCT ID NCT06955767

Recruiting now Diagnosis Sponsor: CHU de Reims Source: ClinicalTrials.gov ↗

First seen Apr 15, 2026 · Last updated May 15, 2026 · Updated 5 times

Summary

This study is testing a new blood test that measures a protein called MMP14 to see if it can better detect colorectal cancer or precancerous growths. Researchers will study 650 adults aged 50 to 74 who already need a colonoscopy after a positive stool test. The goal is to find a cutoff value that accurately identifies who truly has cancer or adenomas, potentially reducing the number of unnecessary colonoscopies in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Damien JOLLY
RECRUITING

Reims, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

COLORECTAL ADENOCARCINOMA COLORECTAL ADENOCARCINOMA